EP3843751
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.7.2020EP published:
27.3.2024EP application number:
20847777.8
EPO information:
European Patent Register
Max expiry date:
29.7.2040
Title in English:
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASESLanguage of the patent:
English
Timeline
Today
30.7.2020EP application
27.3.2024EP Publication
Owner
Name:
Ascentage Pharma (Suzhou) Co., Ltd.Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
Name:
Ascentage Pharma Group Corp LimitedAddress:
9/F, Wah Yuen Building 149 Queen's Road Central, Hong Kong, HK
Inventor
Name:
YANG, DajunAddress:
Suzhou, Jiangsu 215000, CN
Name:
ZHAI, YifanAddress:
Suzhou, Jiangsu 215000, CN
Name:
FANG, Douglas DongAddress:
Suzhou, Jiangsu 215000, CN
Name:
TANG, QiuqiongAddress:
Suzhou, Jiangsu 215000, CN
Priority
Number:
PCT/CN2019/098625Date:
31.7.2019Country:
WO
Number:
202010631089Date:
3.7.2020Country:
CN
Classification
Categories:
A61K 31/496, A61K 31/55, A61P 35/00, A61P 35/02, A61P 35/04